Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alfuzosin-induced hepatotoxicity.

S Zabala1, C Thomson, S Valdearcos

  • 1Service of Internal Medicine, Hospital Obispo Polanco, Avda. Ruiz Jarabo s/n, E-44002 Teruel, Spain. 222438@cunit.unizar.es

Journal of Clinical Pharmacy and Therapeutics
|April 20, 2000
PubMed
Summary

Alfuzosin may cause severe liver injury, presenting as mixed hepatitis. This drug-induced hepatic injury resolved after discontinuing alfuzosin, with normal liver function tests.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic adjustments and oxidative constraints: transition from intracapsular confinement to pelagic larval life in the marine gastropod Crepipatella peruviana.

Marine environmental research·2025
Same author

Intertidal encapsulated embryos exposed to environmental stressors associated with the tidal cycle: A study based on oxidative stress and antioxidant response in early stages of the muricid snail Acanthina monodon.

Marine environmental research·2025
Same author

Dark matter axion search using a Josephson Traveling wave parametric amplifier.

The Review of scientific instruments·2023
Same author

Search for a Dark-Matter-Induced Cosmic Axion Background with ADMX.

Physical review letters·2023
Same author

A novel surgical treatment of type 3 congenital elbow luxation in a dog.

Australian veterinary journal·2023
Same author

Measuring school level attributable risk to support school-based HPV vaccination programs.

BMC public health·2022

Area of Science:

  • Hepatology
  • Pharmacology
  • Toxicology

Background:

  • Drug-induced hepatic injury (DIHI) is a significant clinical concern due to the liver's central role in drug metabolism.
  • The precise mechanisms underlying DIHI are often complex and not fully elucidated for many medications.

Observation:

  • A case of severe acute mixed hepatitis, encompassing both cholestatic and hepatocellular patterns, is presented.
  • This specific liver injury was potentially linked to the use of alfuzosin, an alpha-1 adrenergic blocker.
  • The patient's presentation mimicked other causes of liver disease, necessitating thorough exclusion of viral, autoimmune, and obstructive biliary etiologies.

Findings:

  • Diagnostic workup excluded viral hepatitis, autoimmune liver disease, and biliary tree obstruction as causes of the observed liver injury.

Related Experiment Videos

  • Cessation of alfuzosin administration led to a complete normalization of liver function test results.
  • This case represents a previously unreported instance of severe acute mixed hepatitis potentially induced by alfuzosin.

    • Implications:

    • This report highlights the potential hepatotoxicity of alfuzosin, adding to the spectrum of known drug-induced liver injuries.
    • Clinicians should consider alfuzosin as a potential cause of acute hepatitis in patients presenting with compatible liver enzyme patterns.
    • Further investigation into the specific mechanisms of alfuzosin-induced liver injury may be warranted to improve patient safety and risk management.